It has the largest and most equipped Warehouse in Iran
The first GMP certificate holder The production line of injectable products and ready-to-inject syringes in the country
one of the biggest Pharmaceutical exporters in the country
the first Manufacturer of enoxaparin sodium ready-to-inject syringe with Enoxan brand in Iran
193 pens Manufactured medicine
45 years of experience With more than 490 personnel
Has a statue Cement of excellence and progress
Rank one Among the manufacturers of cardiovascular drugs in the country
بنر مروری بر تاریخچه
Alborz Daru Collection

An overview of history

Alborz Daru, the largest manufacturer of cardiovascular drugs in Iran, was registered in 1355 under the name "International Products". In 1358, it was renamed as "Toli Pharma" and in 1363, it was renamed as "Alborz Daro" (special shares). In 1375, the company became a public company and joined the list of stock market companies. Alborz Daru, the largest manufacturer of cardiovascular drugs in Iran, was registered in 1355 under the name "International Products". In 1358, it was renamed as "Toli Pharma" and in 1363, it was renamed as "Alborz Daro" (special shares). In 1375, the company became a public company and joined the list of stock market companies.

The directional elements of the collection

A brief description of

Mission Creating value for key stakeholders and contributing to sustainable development through promoting public health by supplying and developing quality human medicinal products, products and raw materials, while taking advantage of human capital and knowledge-based technologies in domestic and foreign markets. Policy Alborz Daru Company is one of the largest and most reliable manufacturers of pharmaceutical products in different forms of solids, liquids and injectable products in the country, which provides products that suit the needs of customers according to the regulations of the Food, Drug and Health Organization of Iran (GMP principles) The approaches of knowledge management, risk management and prevention of human accidents and environmental pollution are at the top of his work.
Management statement Management statement Alborz Daro's strategies currently include developing cooperation with foreign companies, developing export markets, focusing on increasing sales of products with high profit margins, developing product portfolios based on new market needs, developing and upgrading GMP requirements, and finally developing and improving internal and external communications. An organization with key stakeholders.
بک گراند مقالات

The latest scientific articles

English Alborz Daru Company has various pharmaceutical products that are included in 13 general categories. By using the link in front, the products related to each drug category can be viewed and reviewed